Search Results for: patient monitors

Over the last decade, the healthcare landscape has been undergoing a significant transformation, with an increasing focus on Value-Based Care (VBC). The VBC model is a replacement for traditional fee-for-service in which providers are reimbursed based on patient health outcomes and the quality of care provided, rather than the quantity.

The global fetal monitoring market reached $190 million in 2023 and is forecast to rise to $230 million in 2028. This article provides a brief snapshot of some of these major trends.

The market for patient monitor consumables is estimated to have been worth $9.2 billion in 2021 (inclusive of multiparameter and single parameter monitoring accessories). This is forecast to fall to $8.6 billion at a CAGR of -1.2% by 2026. The market saw a swift uptick in demand (42% annual growth) in 2020 as a direct result of the global COVID-19 pandemic, driving significant demand for respiratory monitoring consumables.

Earlier this month, Philips announced its plan to acquire France-based Cardiologs. This will be Philips’ third acquisition within its diagnostic cardiology and patient monitoring segment in less than a year.

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death. Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease.

The Remote Patient Monitoring (RPM) market, though still facing a number of teething issues, has potential for significant levels of growth over the coming years. Since Signify Research’s 2022 iteration of its Remote Patient Monitoring – World report, the market has evolved, but still faces several of the same challenges as it did two years ago. The push both during and post-Covid towards more decentralized and virtual models of care delivery continue to steer the market towards further RPM adoption, the pressures regarding a challenging economic climate remain, along with providers burdened with tight operating margins and the ever-present issue of staffing shortages.

As part of our Innovator Series, Signify Research was able to meet up with Dr. Michael Marino, DO, MBA who is Chief, IS Operations/Clinical Systems, at St. Joseph Health, an Integrated Healthcare Delivery System. I spoke with Dr. Marino about how St. Joseph’s was pioneering the use of technology for patient engagement, population health management and telehealth.

The Clinical Care market has been a hotbox of activity in recent years, with product recalls, supply constraints, increasing costs of production and growing presence of lower cost vendors all placing strain on some of its largest competitors.

Earlier in June, the EuroAnaesthesia annual congress was held in the sunny delights of Glasgow, Scotland. Sustainability was the buzz topic at the event and was highlighted by the dedicated “Dear Green Place”, deemed a space for exploring, learning, meeting, and talking about sustainability. As such, it was clear why Glasgow was chosen for this year’s event with a large play on Glasgow’s Gaelic name, Glaschu, which means “Green Glen.”

Without a doubt 2020 has been a devastating year for many; the impact of COVID-19 on both personal lives and businesses has had long-term consequences. At the end of September, the number of COVID-19 cases fell just short of 350 million, with just over 1 million deaths reported.

China-based Comen was the most recent vendor to announce it has received MDR approval for its respiratory fleet. Its V2, V5, V6, V8, NV10, NV50, NV60, and NV70 ventilators have now received CE-marking through the MDR approval process.